Form 4 for ENOV Enovis CORP
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001209191-22-014361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-01 | 2022-02-25+ | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | S - Sale | $41.24 | -33.3K | 172.1K | -16% | -$1.37M |
| 2022-03-01 | 2022-02-25 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | A - Grant | $0.00 | +62.8K | 234.9K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $.001 | 2022-02-28 | S | D | 31,274 | $41.18 | 203,638 | D | — | — | (F1) The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). |
| 2 | Common | Common stock, par value $.001 | 2022-02-25 | A | A | 62,821 | $0.00 | 234,912 | D | — | — | (F2) Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021. |
| 3 | Common | Common stock, par value $.001 | 2022-02-25 | S | D | 2,024 | $42.18 | 172,091 | D | — | — | (F1) The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs"). |